UC Davis University of California - Davis MIND Institute
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hagerman, Randi J
NCT05358886: A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Recruiting
3
150
US
BPN14770/ zatolmilast, Placebo
Tetra Discovery Partners
Fragile X Syndrome
06/25
09/25
RECONNECT, NCT04977986 / 2021-002542-33: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults with Fragile X Syndrome

Recruiting
3
250
Europe, US, RoW
ZYN002 - transdermal gel, cannabidiol formulated as a clear gel that can be applied to the skin (transdermal delivery), Placebo, Placebo Comparator, Matching Placebo
Zynerba Pharmaceuticals, Inc., Zynerba Pharmaceuticals, Inc.
Fragile X Syndrome
05/25
05/25
NCT03479476: A Trial of Metformin in Individuals With Fragile X Syndrome

Completed
2/3
120
Canada, US
Placebo Medication, Placebo, Metformin, Glumetza, Glucophage, Fortamet, Riomet
University of California, Davis, University of Alberta, St. Justine's Hospital
Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked, Genetic Diseases, X-Linked, Trinucleotide Repeat Expansion, Fra(X) Syndrome, Intellectual Disability, FXS, Neurobehavioral Manifestations, Sex Chromosome Disorders
05/24
05/24
NCT05163808: A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Recruiting
2/3
150
US
zatolmilast, BPN14770, Placebo
Tetra Discovery Partners
Fragile X Syndrome
09/25
12/25
NCT05233579: Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS

Completed
N/A
15
US
Sulforaphane, Avmacol
University of California, Davis
Fragile X Associated Tremor/Ataxia Syndrome (Fxtas) (Diagnosis)
01/23
01/23

Download Options